Drug treatment of type 2 diabetes in adults
Andrew Lowey Quality assurance/research pharmacist, Trust Headquarters, St James’s Hospital, Leeds
This article outlines the pharmacological management of type 2 diabetes and its complications in adults. Practical aspects of the drug options and the evidence supporting their use are discussed. The need for a holistic, patient-centred approach to achieve the treatment goals of glycaemic control and prevention of complications is emphasised.
20, 11, 55-64.
This article has been subject to double blind peer review
Want to read more?
Subscribe for unlimited access
Try 1 month’s access for just £1 and get:
Your subscription package includes:
- Full access to nursingstandard.com and the Nursing Standard app
- The monthly digital edition
- RCNi Portfolio and interactive CPD quizzes
- RCNi Learning with 200+ evidence-based modules
- 10 articles a month from any other RCNi journal
Already subscribed? Log in
Alternatively, you can purchase access to this article for the next seven days. Buy now